Tenon Medical, Inc.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $4.6M
- Price
- $6.83
- % Change (Daily % change from the live per-ticker quote feed.)
- -3.39%
- Volume
- 560.9K
About
Tenon Medical, Inc., a medical device company, engages in the development of implant for the treatment of severe lower back pain in the United States. The company offers Catamaran SI-Joint Fusion System, an invasive approach to the sacroiliac joint (SI Joint) using a titanium implant for treatment of the most common types of SI Joint disorders that cause lower back pain. It also provides Catamaran Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, transfixing the SI Joint along its longitudinal axis. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.
Quick stats
Shares outstanding667.0K
Computed float578.9K
Float / shares86.8%
Cash runway (months)0.1
Key info
SectorHealthcare
IndustryMedical - Devices
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001560293
Websitehttps://www.tenonmed.com
AI Summary
AI-generated1/12
majormixedearnings
Tenon Medical Reports Second Quarter 2026 Financial Results
Tenon Medical reported Q2 revenue of $1.3 million, up 127% year-over-year, with gross profit rising 232% to $0.8 million and margins expanding to 64%.
Subsequent to the quarter, the company received FDA 510(k) clearance for its updated Catamaran system and achieved record monthly case volume, supported by a 98% increase in training events.
To bolster its balance sheet, the firm closed a $4.2 million public offering and executed a 1-for-35 reverse stock split to regain compliance with Nasdaq minimum bid price requirements.
Red flags
- 1-for-35 reverse stock split signals listing compliance risk
- $5.2 million in convertible notes mature on September 11, 2026, with cash at $1.7 million prior to subsequent offering